Anh Nguyen, MD, MBA, is a clinician-scientist and a Vice President, Therapeutic Sector Lead at Asklepios BioPharmaceutical (AskBio), who develops in vivo gene therapies for rare disease. Previously, Nguyen served as a medical officer for both the US Food and Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS). He began his industry career as a global medical director developing biologics and combination products at Baxter.
Nguyen is a Kauffman Fellow, FDA Commissioner’s Fellow, and a Robert Wood Johnson Foundation Health Policy Fellow. During his RWJF fellowship on the US Senate Committee on Health, Education, Labor and Pensions he helped draft legislative policies as part of the
“21st Century Cures Act” – enacted into law in 2016. Nguyen regularly volunteers as active senior medical staff at the NIH and is a recipient of the NIH Director’s Award. Nguyen received a combined BS-MD degree from the New Jersey Medical School, and an MBA from the University of Chicago Booth School of Business. He completed both his residency in anesthesiology and a fellowship in adult and pediatric cardiovascular anesthesiology at the Massachusetts General Hospital – Harvard Medical School.